Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery

Journal of Pharmaceutical Sciences
R K DeLongR L Juliano

Abstract

This study evaluates polyamidoamine PAMAM "starburst" dendrimers (generation 3, Mr 6909) as a potential delivery vehicle for oligonucleotides. Complexes between dendrimer and phosphorothioate oligonucleotides were observed by agarose gel electrophoresis and were positive, negative, or neutral in charge depending on stoichiometry. Complexes were stable in 50% serum to variations in pH (3, 5, and 10) and ionic strength (0-500 mM). Ultrafiltration and gel filtration characterization indicated that the dendrimer:oligonucleotide complexes were primarily < 100 kD, although some larger complexes were formed at oligonucleotide excess. Use of dendrimers resulted in a 50-fold enhancement in cell uptake of oligonucleotide as determined by flow cytometry, and enhanced cytosolic and nuclear availability, as shown by confocal microscopy. These data support the further evaluation of dendrimers for oligonucleotide delivery in cell culture and in vivo.

References

Sep 1, 1993·Bioconjugate Chemistry·J Haensler, F C Szoka
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·J F Kukowska-LatalloJ R Baker

❮ Previous
Next ❯

Citations

Jan 5, 2007·Der Radiologe·L MatuszewskiC Bremer
Sep 27, 2005·Pharmaceutical Research·Hyunmin KangRudolph L Juliano
Mar 22, 2007·Pharmaceutical Research·Khee Dong EomHoon Yoo
Jun 3, 2004·Biomaterials·Woo-Jeong ChoiChong-Kook Kim
Mar 12, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marcelo MamedeJunji Konishi
May 12, 2000·Biochimica Et Biophysica Acta·C F Bennett, L M Cowsert
Oct 18, 2000·Advanced Drug Delivery Reviews·S AkhtarP Sayyed
Apr 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·I JääskeläinenA Urtti
Jan 6, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M BertonR Gurny
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·I LebedevaM Vilenchik
Mar 21, 2001·Drug Discovery Today·M D. HughesS Akhtar
Jan 23, 1999·Current Opinion in Chemical Biology·Y Kim, S C Zimmerman
Jun 20, 2002·Journal of Biotechnology·Kristen Sadler, James P Tam
Jul 8, 2000·Pharmaceutical Science & Technology Today·J D EichmanJ R Baker
Jan 10, 2012·Langmuir : the ACS Journal of Surfaces and Colloids·Brooke Parker-EsquivelRobert K DeLong
Mar 30, 2005·Chemical Communications : Chem Comm·Sabine FuchsA Dieter Schluter
Aug 10, 2000·Nucleic Acids Research·N MignetJ C François
Jul 6, 2004·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hidetoshi Arima
Apr 1, 2011·Therapeutic Delivery·Joel C SunshineJordan J Green
Feb 6, 2016·Nanoscale Research Letters·Valeria Márquez-MirandaCarolina Otero
May 28, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Karim SnoussiPeter C M van Zijl
Jul 25, 2014·BioMed Research International·Gyati Shilakari AsthanaSuresh Prasad Vyas
Mar 23, 2011·International Journal of Pharmaceutics·Thomas SchmidtsFrank Runkel
Oct 27, 2007·Nanomedicine : Nanotechnology, Biology, and Medicine·Lajos BaloghMohamed K Khan
Jul 20, 2007·International Journal of Radiation Oncology, Biology, Physics·Satoshi AnaiCharles J Rosser
Jun 5, 2004·Biochemical and Biophysical Research Communications·P MedberryR K DeLong
Dec 6, 2006·Annals of the New York Academy of Sciences·R L Juliano
Jul 11, 2009·Journal of Biomedical Materials Research. Part a·Chunsheng KangYunting Zhang
Nov 17, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·J K W LamS Stolnik
Jun 5, 2003·Expert Opinion on Therapeutic Targets·Jenny Godfray, Peter Estibeiro
Feb 7, 2002·The Journal of Pharmacy and Pharmacology·Crispin R Dass
Nov 18, 2005·Advanced Drug Delivery Reviews·Kelly M KitchensHamidreza Ghandehari
Jun 19, 2007·Biochimica Et Biophysica Acta·Jean-Pierre GilletJosé Remacle
Feb 2, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joshua D RamseyDaniel W Pack

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.